Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Current Leases (2019 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 7 years of Current Leases data on record, last reported at $4.0 million in Q1 2025.

  • For Q1 2025, Current Leases fell 4.64% year-over-year to $4.0 million; the TTM value through Feb 2025 reached $4.0 million, down 4.64%, while the annual FY2024 figure was $4.0 million, 212.05% up from the prior year.
  • Current Leases reached $4.0 million in Q1 2025 per LFCR's latest filing, down from $4.1 million in the prior quarter.
  • Across five years, Current Leases topped out at $5.0 million in Q1 2022 and bottomed at $977000.0 in Q2 2021.
  • Average Current Leases over 5 years is $3.0 million, with a median of $4.0 million recorded in 2025.
  • Peak YoY movement for Current Leases: crashed 77.91% in 2021, then surged 401.99% in 2022.
  • A 5-year view of Current Leases shows it stood at $1.2 million in 2021, then soared by 311.58% to $5.0 million in 2022, then crashed by 76.2% to $1.2 million in 2023, then skyrocketed by 245.01% to $4.1 million in 2024, then fell by 3.64% to $4.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $4.0 million in Q1 2025, $4.1 million in Q4 2024, and $4.1 million in Q3 2024.